Nektar Therapeutics
NKTR
$0.8968
$0.08149.98%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 244.50M | 271.24M | 289.24M | 303.62M | 372.66M |
| Total Receivables | 2.12M | 2.90M | 5.43M | 2.25M | 3.43M |
| Inventory | -- | 14.47M | 16.24M | 16.10M | 15.13M |
| Prepaid Expenses | 2.85M | 2.38M | 4.16M | 4.41M | 5.79M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 37.01M | 4.21M | 4.77M | 4.33M | 2.01M |
| Total Current Assets | 286.48M | 295.19M | 319.84M | 330.70M | 399.03M |
|
|
|||||
| Total Current Assets | 286.48M | 295.19M | 319.84M | 330.70M | 399.03M |
| Net Property, Plant & Equipment | 12.43M | 24.43M | 34.74M | 36.86M | 38.70M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.52M | 4.31M | 4.66M | 4.64M | 4.52M |
| Total Assets | 307.97M | 343.33M | 396.01M | 398.03M | 442.24M |
|
|
|||||
| Total Accounts Payable | 8.58M | 6.48M | 8.76M | 9.85M | 3.29M |
| Total Accrued Expenses | 29.23M | 26.16M | 19.93M | 16.46M | 22.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.50M | 21.34M | 19.37M | 19.26M | 19.10M |
| Total Finance Division Other Current Liabilities | 8.28M | 3.36M | 4.35M | 5.70M | 7.07M |
| Total Other Current Liabilities | 8.28M | 3.36M | 4.35M | 5.70M | 7.07M |
| Total Current Liabilities | 67.58M | 57.33M | 52.41M | 51.27M | 52.11M |
|
|
|||||
| Total Current Liabilities | 67.58M | 57.33M | 52.41M | 51.27M | 52.11M |
| Long-Term Debt | 97.83M | 107.51M | 117.86M | 112.63M | 123.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 86.76M | 90.76M | 94.71M | 98.52M | 102.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.91M | 8.05M | 4.33M | 4.64M | 4.96M |
| Total Liabilities | 259.08M | 263.65M | 269.31M | 267.05M | 282.88M |
|
|
|||||
| Common Stock & APIC | 3.66B | 3.65B | 3.64B | 3.61B | 3.60B |
| Retained Earnings | -3.60B | -3.57B | -3.51B | -3.48B | -3.44B |
| Treasury Stock & Other | -2.65M | -3.49M | -3.40M | 80.00K | -6.35M |
| Total Common Equity | 48.88M | 79.69M | 126.71M | 130.99M | 159.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.88M | 79.69M | 126.71M | 130.99M | 159.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.88M | 79.69M | 126.71M | 130.99M | 159.37M |
|
|
|||||
